Xarelto And Eylea Keep Bayer Buoyant
Despite Shadow Cast By Roundup Lawsuits
The German major's two leading products continue to perform well but there are not many potential blockbusters in the pipeline.
The German major's two leading products continue to perform well but there are not many potential blockbusters in the pipeline.